Company Filing History:
Years Active: 2022-2023
Title: **Inventor Profile: Jane Alexandra Potter**
Introduction
Jane Alexandra Potter is an innovative inventor based in Fife, GB. With a remarkable portfolio of two patents, she has made significant contributions to the field of viral treatments. Her groundbreaking research focuses on the treatment and prevention of RSV infections and the modulation of immune responses.
Latest Patents
Jane's latest patents include a novel viral treatment and a modified protein. The viral treatment patent outlines molecules designed for compositions, medicaments, and methods aimed at treating or preventing RSV infections and their associated pathologies. This invention is particularly noteworthy as it leverages molecules with an affinity for sialic acid, which play a crucial role in the pathogenesis of various viral infections.
The second patent, related to modified proteins, describes a cohort of sialic acid binding molecules that incorporate modified carbohydrate binding modules (CBMs). These modified CBMs are designed to minimize adverse events linked to host immune responses and enhance therapeutic applications, including the treatment of cancer and sepsis, as well as serving as mucosal adjuvants.
Career Highlights
Jane Alexandra Potter has established herself as a leader in her field, working with Pneumagen Limited. Her expertise and innovative approach to research have positioned her as an asset to the company, where she drives advancements in viral treatment solutions.
Collaborations
Throughout her career, Jane has collaborated with talented individuals such as Helen Connaris and Lei Yang. These partnerships have been instrumental in fostering innovation and pushing the boundaries of research in virology and immunology.
Conclusion
Jane Alexandra Potter exemplifies the spirit of innovation in medicine, particularly in the realm of viral treatments. Her patents highlight the potential of science to address pressing health challenges, and her work at Pneumagen Limited signifies a commitment to improving patient outcomes. Through her collaborations and research, Jane continues to inspire the next generation of inventors.